ӳ��ý

Publications

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030.

Parsons HA, Blewett T, Chu X, et al. Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030. Annals of oncology : official journal of the European Society for Medical Oncology. 2023. doi:10.1016/j.annonc.2023.08.004

Clinical outcomes of de novo versus relapsed early metastatic testicular seminoma treated with contemporary radiation therapy.

Rosen DB, Ghosh A, Niemierko A, et al. Clinical outcomes of de novo versus relapsed early metastatic testicular seminoma treated with contemporary radiation therapy. International journal of radiation oncology, biology, physics. 2023. doi:10.1016/j.ijrobp.2023.09.010

Gut microbiome perturbation, antibiotic resistance, and Escherichia coli strain dynamics associated with international travel: a metagenomic analysis.

Worby CJ, Sridhar S, Turbett SE, et al. Gut microbiome perturbation, antibiotic resistance, and Escherichia coli strain dynamics associated with international travel: a metagenomic analysis. The Lancet. Microbe. 2023. doi:10.1016/S2666-5247(23)00147-7

Plasma metabolite profiles associated with the World Cancer Research Fund/American Institute for Cancer Research lifestyle score and future risk of cardiovascular disease and type 2 diabetes.

Rios S, García-Gavilán JF, Babio N, et al. Plasma metabolite profiles associated with the World Cancer Research Fund/American Institute for Cancer Research lifestyle score and future risk of cardiovascular disease and type 2 diabetes. Cardiovascular diabetology. 2023;22(1):252. doi:10.1186/s12933-023-01912-6

Plasma metabolomic profiles associated with mortality and longevity in a prospective analysis of 13,512 individuals.

Wang F, Tessier AJ, Liang L, et al. Plasma metabolomic profiles associated with mortality and longevity in a prospective analysis of 13,512 individuals. Nature communications. 2023;14(1):5744. doi:10.1038/s41467-023-41515-z

Natalizumab Treatment of Relapsing Remitting Multiple Sclerosis Has No Long-Term Effects on the Proportion of Circulating Regulatory T Cells.

Tanasescu R, Frakich N, Chou IJ, et al. Natalizumab Treatment of Relapsing Remitting Multiple Sclerosis Has No Long-Term Effects on the Proportion of Circulating Regulatory T Cells. Neurology and therapy. 2023. doi:10.1007/s40120-023-00539-9

Getting an aMPLe grasp on hematopoiesis.

Joubran S, Sankaran VG. Getting an aMPLe grasp on hematopoiesis. Cell. 2023;186(19):4005-4006. doi:10.1016/j.cell.2023.08.015

Guidelines for Evaluating the Comparability of Down-Sampled GWAS Summary Statistics.

Williams CM, Poore H, Tanksley PT, et al. Guidelines for Evaluating the Comparability of Down-Sampled GWAS Summary Statistics. Behavior genetics. 2023. doi:10.1007/s10519-023-10152-z

Development and Multicenter Case-Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction.

Salari K, Sundi D, Lee JJ, et al. Development and Multicenter Case-Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction. Clinical cancer research : an official journal of the American Association for Cancer Research. 2023;29(18):3668-3680. doi:10.1158/1078-0432.CCR-23-0570

Community-developed checklists for publishing images and image analyses.

Schmied C, Nelson MS, Avilov S, et al. Community-developed checklists for publishing images and image analyses. Nature methods. 2023. doi:10.1038/s41592-023-01987-9